|
End-of-day quote
Nasdaq
13/11/2026
|
5-day change | 1st Jan Change | ||
| 8.480 USD | +0.24% |
|
+0.36% | -42.51% |
| 09-01 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
| Market Cap | 49.51M 44.98M 41.56M 37.54M 70.84M 4.65B 73.33M 500M 198M 2.49B 186M 182M 7.9B | P/E 2026 * |
-40.4x | P/E 2027 * | -283x |
|---|---|---|---|---|---|
| Enterprise Value | 49.51M 44.98M 41.56M 37.54M 70.84M 4.65B 73.33M 500M 198M 2.49B 186M 182M 7.9B | EV / Sales 2026 * |
5.32x | EV / Sales 2027 * | 3.02x |
| Free-Float |
46.7% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DXR | End-of-day quote | |
| DXR | Delayed | ||
| DXR | Real-time | ||
| DX5 | Delayed |
Last Transcript: Daxor Corporation
| 1 day | +0.24% | ||
| 1 week | +0.36% | ||
| Current month | -7.83% | ||
| 1 month | -16.86% | ||
| 3 months | -18.46% | ||
| 6 months | -21.12% | ||
| Current year | -42.51% |
| 1 week | 8.24 | 8.72 | |
| 1 month | 8.24 | 10.12 | |
| Current year | 8.24 | 14.75 | |
| 1 year | 8.24 | 14.76 | |
| 3 years | 6.55 | 14.76 | |
| 5 years | 6.55 | 14.76 | |
| 10 years | 3.4 | 24.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2013 | |
Robert Michel
DFI | Director of Finance/CFO | 69 | 28/09/2018 |
John Jefferies
CTO | Chief Tech/Sci/R&D Officer | - | 05/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James Lombard
BRD | Director/Board Member | 91 | 01/01/1989 |
| Chairman | 56 | 14/02/2017 | |
Edward Feuer
BRD | Director/Board Member | 70 | 22/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/28/26 A | Free | Chief Technology Officer | 2,451 | 0.0420% | ||
| 6/23/26 A | Free | Director | 2,500 | 0.0429% | ||
| 4/8/26 A | Buy | Chief Executive Officer | 1,000 | 0.0172% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.24% | +0.36% | -34.77% | +16.74% | 49.51M | ||
| -0.75% | -7.06% | -5.37% | +87.98% | 14.23B | ||
| -4.37% | -12.77% | -8.77% | +86.99% | 9.6B | ||
| 0.00% | +1.71% | -15.19% | +28.33% | 9.06B | ||
| -1.19% | -6.88% | -20.55% | -19.55% | 6.79B | ||
| -1.90% | -8.88% | -5.89% | +94.40% | 6.46B | ||
| -1.83% | -3.31% | +3.46% | -0.27% | 6.33B | ||
| -0.61% | +2.78% | +12.74% | +23.33% | 4.99B | ||
| -0.40% | -0.88% | +0.60% | +11.26% | 3.81B | ||
| -2.14% | -1.61% | - | - | 3.69B | ||
| Average | -1.06% | -1.70% | -8.19% | +36.58% | 7B | |
| Weighted average by Cap. | -1.27% | -2.31% | -6.35% | +48.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.3M 8.45M 7.81M 7.05M 13.31M 873M 13.78M 93.88M 37.2M 469M 34.9M 34.16M 1.48B | 16.4M 14.9M 13.77M 12.43M 23.47M 1.54B 24.29M 166M 65.6M 826M 61.54M 60.24M 2.62B |
| Net income | -1.2M -1.09M -1.01M -910K -1.72M -113M -1.78M -12.11M -4.8M -60.47M -4.5M -4.41M -192M | -200K -182K -168K -152K -286K -18.78M -296K -2.02M -800K -10.08M -750K -735K -31.92M |
| Net Debt | - | - |
Employees
45
Sector
Closed End Funds
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | $8.480 | +0.24% | 16,805 |
| 12/11/26 | $8.460 | -0.70% | 5,715 |
| 11/11/26 | $8.520 | -0.12% | 3,586 |
| 10/11/26 | $8.530 | -2.18% | 6,128 |
| 09/11/26 | $8.720 | +3.20% | 6,781 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.480USD
Average target price
20.00USD
Spread / Average Target
+135.85%
- Stock Market
- Stocks
- DXR Stock
Select your edition
All financial news and data tailored to specific country editions
















